Search research articles
Contact Us
Filters
Showing results (111-120 of 127) with videos related to
Page
of 13
Sort By:
European Journal of Neurology
|
December 20, 2013
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study
A Shirani, Y Zhao, M E Karim, et al.
AIDS Research and Human Retroviruses
|
June 30, 2000
HTLV type I/II in British Columbia Amerindians: a seroprevalence study and sequence characterization of an HTLV type IIa isolate
A A Peters, M B Coulthart, J J Oger, et al.
Annals of Neurology
|
August 1, 1989
Chronic progressive multiple sclerosis: serial magnetic resonance brain imaging over six months
R A Koopmans, D K Li, J J Oger, et al.
Annals of the New York Academy of Sciences
|
July 21, 1998
Rapsyn antibodies in myasthenia gravis
M A Agius, S Zhu, C A Kirvan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 28, 2015
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years
E L MacMillan, R Tam, Y Zhao, et al.
Neurology
|
April 13, 2012
Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial
D S Goodin, A T Reder, G C Ebers, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
August 28, 2012
Insights into origins of Human T-cell Lymphotropic Virus Type 1 based on new strains from aboriginal people of Canada
Anton Andonov, Michael B Coulthart, Marcos Pérez-Losada, et al.
Neurology
|
October 7, 2011
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
M S Freedman, A Bar-Or, J Oger, et al.
Neurology
|
January 1, 1989
Biologic versus clinical MS
D W Paty, K A Eisen, J J Oger, et al.
European Journal of Neurology
|
April 8, 2015
Beta-interferon exposure and onset of secondary progressive multiple sclerosis
T Zhang, A Shirani, Y Zhao, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 127) with videos related to
Sort By:
Page
of 13
European Journal of Neurology
|
December 20, 2013
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study
A Shirani, Y Zhao, M E Karim, et al.
AIDS Research and Human Retroviruses
|
June 30, 2000
HTLV type I/II in British Columbia Amerindians: a seroprevalence study and sequence characterization of an HTLV type IIa isolate
A A Peters, M B Coulthart, J J Oger, et al.
Annals of Neurology
|
August 1, 1989
Chronic progressive multiple sclerosis: serial magnetic resonance brain imaging over six months
R A Koopmans, D K Li, J J Oger, et al.
Annals of the New York Academy of Sciences
|
July 21, 1998
Rapsyn antibodies in myasthenia gravis
M A Agius, S Zhu, C A Kirvan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 28, 2015
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years
E L MacMillan, R Tam, Y Zhao, et al.
Neurology
|
April 13, 2012
Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial
D S Goodin, A T Reder, G C Ebers, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
August 28, 2012
Insights into origins of Human T-cell Lymphotropic Virus Type 1 based on new strains from aboriginal people of Canada
Anton Andonov, Michael B Coulthart, Marcos Pérez-Losada, et al.
Neurology
|
October 7, 2011
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
M S Freedman, A Bar-Or, J Oger, et al.
Neurology
|
January 1, 1989
Biologic versus clinical MS
D W Paty, K A Eisen, J J Oger, et al.
European Journal of Neurology
|
April 8, 2015
Beta-interferon exposure and onset of secondary progressive multiple sclerosis
T Zhang, A Shirani, Y Zhao, et al.
Page
of 13